2-aminopurine has been researched along with Hepatitis B in 61 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 27 (44.26) | 18.2507 |
2000's | 33 (54.10) | 29.6817 |
2010's | 1 (1.64) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bock, CT; Finger, A; Heidrich, B; Manns, MP; Michel, G; Rosenau, J; Tillmann, HL; Wedemeyer, H; Wiegand, J | 1 |
Aoki, FY; Leung, V; Mubareka, S; Vinh, DC | 1 |
Hollander, A; Lindh, G; Sangfelt, P; Uhnoo, I; Weiland, O | 1 |
Fischer, L; Meier, D; Rogiers, X; Sterneck, M; Zöllner, B | 1 |
Brown, TJ; McCrary, M; Tyring, SK | 1 |
Villamil, FG | 1 |
Terrault, NA | 1 |
Huang, DS; Liang, TB; Wang, WL; Wu, J; Xu, X; Zheng, SS | 1 |
Berenguer, M; Wright, TL | 1 |
Acar, K; Aki, Z; Bozdayi, G; Haznedar, R; Sucak, GT; Yağci, M | 1 |
Angelousi, AG; Charatsis, GG; Falagas, ME; Lampropoulos, KM; Panos, GZ | 1 |
Cornu, C; Geubel, A; Goffin, E; Horsmans, Y; Pirson, Y; van Ypersele De Strihou, C | 1 |
de Man, RA; Heijtink, RA; Niesters, HG; Schalm, SW | 2 |
Böker, KH; Krüger, M; Manns, MP; Pichlmayr, R; Ringe, B | 1 |
Cirelli, R; Herne, K; Lee, P; McCrary, M; Tyring, SK | 1 |
Atkinson, G; Brown, JL; Crossey, M; Galassini, R; Georgiou, P; Howells, C; Karayiannis, P; Main, J; Thomas, HC | 1 |
Bechstein, WO; Berg, T; Haller, GW; Hopf, U; Neuhaus, P; Neuhaus, R; Raakow, R | 1 |
Böker, KH; Kruger, M; Manns, MP; Zeidler, H | 1 |
Gayowski, T; Marino, IR; Singh, N; Wagener, MM; Wannstedt, CF | 1 |
Bañares, R; Baños, E; Clemente, G; Cos, E; de Diego, A; García-Durán, F; Piqueras, B; Roldán, P; Salcedo, M | 1 |
Terrault, NA; Wright, TL | 1 |
Böckler, D; Geoghegan, J; Klein, M; Korn, K; Scheele, J; Schmidt, K; Wittekind, C | 1 |
Perrillo, RP | 2 |
Au, WY; Lau, GK; Lee, CK; Liang, R; Lim, WL; Wu, PC | 1 |
Bain, VG; Davis, JE; Erb, SR; Fischer, KP; Kneteman, NM; Ma, MM; Tyrrell, DL; Yoshida, EM | 1 |
Arnold, JC; Golling, M; Herfarth, C; Otto, G; Rudek, B; Theilmann, L | 1 |
Bartholomeusz, A; Groenen, LC; Locarnini, SA | 1 |
Mutimer, D | 1 |
Busuttil, RW; Han, SH; Hiserodt, D; Holt, C; Imagawa, D; Kinkhabwala, M; Martin, P; Murray, N; Rudich, S; Seu, P | 1 |
Bartholomeusz, AI; de Man, RA; Locarnini, SA; Niesters, HG; Zondervan, PE | 1 |
Kumashiro, R; Sata, M | 1 |
Fischer, L; Gaeta, GB; Günther, S; Jung, MC; Santantonio, T; Sterneck, M; von Breunig, F; Will, H | 1 |
Bock, T; Böker, KH; Bruns, I; Condreay, LD; Gauthier, J; Glowienka, M; Jäckel, E; Manns, MP; Oldhafer, K; Raab, HR; Tillmann, HL; Trautwein, C | 1 |
Cane, PA; Mutimer, D; Pillay, D | 1 |
Lau, GK; Lee, CK; Liang, R | 1 |
Locarnini, SA; Shaw, T | 1 |
Bechstein, WO; Berg, T; Müller, AR; Neuhaus, P; Neuhaus, R; Rayes, N; Seehofer, D | 1 |
Cane, PA; Cook, P; Dowling, D; Elias, E; Mutimer, D; O'Donnell, K; Pillay, D; Ratcliffe, D; Shaw, J | 1 |
Kruger, M; Lake, JR; Perrillo, RP; Sievers, T | 1 |
Bechstein, WO; Berg, T; Hopf, U; Müller, AR; Neuhaus, P; Neuhaus, R; Rayes, N; Seehofer, D | 1 |
Fischer, L; Rogiers, X; Sterneck, M; Zöllner, B | 1 |
Chaudhary, R; Fonseca, K; Lee, SS; Myers, RP | 1 |
Bechstein, WO; Hopf, U; Naumann, U; Neuhaus, P; Neuhaus, R; Rayes, N; Seehofer, D | 1 |
Berenguer, J; Berenguer, M; Bustamante, M; Carrasco, D; Gobernado, M; Mir, J; Moya, A; Pastor, MA; Prieto, M; Rayón, M | 1 |
Grande Santamaría, L; Romero Gómez, M; Suárez García, E | 1 |
Forns, X; Sánchez-Tapias, JM | 1 |
Cahlin, C; Friman, S; Olausson, M | 1 |
Atkinson, GF; Barnass, S; Griffin, KE; Manns, MP; Neuhaus, P; Vollmar, J; Yeang, Y; Young, CL | 1 |
Delaney, WE; Locarnini, S; Shaw, T | 1 |
Bowden, S; Lau, GK; Lewin, SR; Locarnini, S; Perelson, AS; Ribeiro, RM; Walters, T | 1 |
Bechstein, WO; Berg, T; Müller, AR; Naumann, U; Neuhaus, P; Neuhaus, R; Rayes, N; Seehofer, D; Steinmüller, T; Tullius, SG | 1 |
Cane, P; Gazzard, B; Matthews, GV; Nelson, M; Pillay, D; Ratcliffe, D | 1 |
Chan, TM; Ho, SK; Lai, KN; Moniri, K; Tang, S | 1 |
Hou, J; Sun, J; Wang, Z | 1 |
Duan, Y; Liang, S; Wang, F; Yuan, G; Zhu, L | 1 |
Ben-Ari, Z; Daudi, N; Dinari, G; Klein, A; Mor, E; Shapira, R; Shouval, D; Tur-Kaspa, R | 1 |
Nguyen, MH; Wright, TL | 1 |
Aulitzky, WE; Einsele, H; Henkes, M; Martin, S | 1 |
16 review(s) available for 2-aminopurine and Hepatitis B
Article | Year |
---|---|
Famciclovir: a focus on efficacy and safety.
Topics: 2-Aminopurine; Antiviral Agents; Famciclovir; Female; Hepatitis B; Hepatitis B virus; Herpesviridae Infections; Herpesvirus 3, Human; Humans; Male; Pregnancy; Pregnancy Complications, Infectious; Simplexvirus; Treatment Outcome | 2010 |
Antiviral agents: Non-antiretroviral [correction of Nonantiviral] drugs.
Topics: 2-Aminopurine; Acyclovir; Antiviral Agents; Chickenpox; Cytomegalovirus Infections; Famciclovir; Foscarnet; Guanine; Hepatitis B; Hepatitis C; Herpes Genitalis; Herpes Simplex; Herpesvirus 3, Human; Herpesvirus 8, Human; Humans; Papillomavirus Infections; Sarcoma, Kaposi; Skin Diseases, Viral; Valacyclovir; Valine | 2002 |
Hepatitis B: progress in the last 15 years.
Topics: 2-Aminopurine; Antiviral Agents; Famciclovir; Hepatitis B; Humans; Immunoglobulins; Liver Transplantation; Postoperative Complications; Reverse Transcriptase Inhibitors; Secondary Prevention | 2002 |
Treatment of recurrence of hepatitis B in transplant patients.
Topics: 2-Aminopurine; Antiviral Agents; Drug Resistance, Microbial; Famciclovir; Hepatitis B; Humans; Immunoglobulins; Lamivudine; Liver Transplantation; Postoperative Care; Reverse Transcriptase Inhibitors; Secondary Prevention | 2003 |
New nucleoside analogues for chronic hepatitis B.
Topics: 2-Aminopurine; Antiviral Agents; Arabinofuranosyluracil; Chronic Disease; Drug Evaluation, Preclinical; Famciclovir; Hepatitis B; Humans; Lamivudine; Nucleosides; Zalcitabine | 1995 |
New developments in antiviral therapy for chronic hepatitis B infection.
Topics: 2-Aminopurine; Antiviral Agents; Arabinofuranosyluracil; Clinical Trials as Topic; Famciclovir; Hepatitis B; Hepatitis, Chronic; Humans; Interferon-alpha; Lamivudine; Treatment Outcome; Zalcitabine | 1995 |
Famciclovir: review of clinical efficacy and safety.
Topics: 2-Aminopurine; Animals; Antiviral Agents; Drug Resistance, Microbial; Famciclovir; Hepatitis B; Herpes Genitalis; Herpes Zoster; Herpesviridae; Herpesvirus 3, Human; Humans | 1996 |
Treatment of posttransplantation hepatitis B.
Topics: 2-Aminopurine; Antiviral Agents; Famciclovir; Ganciclovir; Hepatitis B; Humans; Lamivudine; Liver Transplantation | 1997 |
Clinical experience with famciclovir against hepatitis B virus.
Topics: 2-Aminopurine; Administration, Oral; Amino Acid Sequence; Antiviral Agents; Drug Resistance, Microbial; Famciclovir; Genes, Viral; Hepatitis B; Hepatitis B virus; Humans; Liver Transplantation; Models, Molecular; Molecular Sequence Data; Mutation; Prodrugs; RNA-Directed DNA Polymerase | 1997 |
[New management of hepatitis B virus].
Topics: 2-Aminopurine; Adrenal Cortex Hormones; Antiviral Agents; Famciclovir; Germanium; Hepatitis B; Humans; Immunologic Factors; Interferons; Interleukin-12; Lamivudine; Organometallic Compounds; Propionates; Reverse Transcriptase Inhibitors; Thymosin | 1999 |
Hepatitis B virus infection and bone marrow transplantation.
Topics: 2-Aminopurine; Antiviral Agents; Biomarkers; Bone Marrow Transplantation; Famciclovir; Hepatitis B; Hepatitis B Antigens; Humans; Liver Diseases; Transplantation, Homologous | 1999 |
Preclinical aspects of lamivudine and famciclovir against hepatitis B virus.
Topics: 2-Aminopurine; Antiviral Agents; Famciclovir; Hepatitis B; Hepatitis B virus; Humans; Lamivudine | 1999 |
Posttransplantation: emerging and future therapies.
Topics: 2-Aminopurine; Antiviral Agents; Drug Therapy, Combination; Famciclovir; Ganciclovir; Hepatitis B; Humans; Lamivudine; Liver Transplantation; Nucleosides; Postoperative Care; Risk Factors; Secondary Prevention; Survival Analysis | 2000 |
Antiviral therapy to prevent and treat hepatitis B virus infection in hepatic allografts.
Topics: 2-Aminopurine; Antiviral Agents; Drug Combinations; Drug Resistance, Microbial; Famciclovir; Ganciclovir; Hepatitis B; Humans; Immunization, Passive; Immunoglobulins; Lamivudine; Liver Transplantation; Survival Rate; Transplantation, Homologous | 2000 |
Resistance of hepatitis B virus to antiviral drugs: current aspects and directions for future investigation.
Topics: 2-Aminopurine; Adenine; Amino Acid Sequence; Animals; Anti-HIV Agents; Antimetabolites; Antiviral Agents; Biological Availability; Cell Line; Clinical Trials as Topic; DNA Replication; DNA-Directed DNA Polymerase; DNA, Viral; Drug Design; Drug Evaluation, Preclinical; Drug Resistance, Multiple; Drug Resistance, Viral; Drug Therapy, Combination; Enzyme Inhibitors; Famciclovir; Gene Products, pol; Hepatitis B; Hepatitis B virus; Hepatitis Viruses; Hepatitis, Animal; HIV; Humans; Lamivudine; Models, Animal; Molecular Sequence Data; Molecular Structure; Nucleosides; Organophosphonates; Sequence Alignment; Sequence Homology, Amino Acid; Species Specificity; Virus Replication | 2001 |
Therapeutic advances in the management of hepatitis B and hepatitis C.
Topics: 2-Aminopurine; Antiviral Agents; Drug Therapy, Combination; Famciclovir; Hepatitis B; Hepatitis C; Humans; Interferon-alpha; Lamivudine; Ribavirin | 2001 |
6 trial(s) available for 2-aminopurine and Hepatitis B
Article | Year |
---|---|
Lamivudine and famciclovir combination therapy with or without addition of interferon-alpha-2b for HBeAg-positive chronic hepatitis B: a pilot study.
Topics: 2-Aminopurine; Adult; Antiviral Agents; DNA, Viral; Drug Therapy, Combination; Famciclovir; Female; Hepatitis B; Hepatitis B e Antigens; Humans; Interferon alpha-2; Interferon-alpha; Lamivudine; Male; Middle Aged; Pilot Projects; Recombinant Proteins | 2002 |
A prospective study on chemotherapy-induced hepatitis B virus reactivation in chronic HBs Ag carriers with hematologic malignancies and pre-emptive therapy with nucleoside analogues.
Topics: 2-Aminopurine; Adult; Aged; Antineoplastic Agents; Antiviral Agents; Chronic Disease; Famciclovir; Female; Hematologic Neoplasms; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Lamivudine; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Nucleosides; Pilot Projects; Prospective Studies; Virus Activation | 2006 |
A double blind, placebo-controlled study to assess the effect of famciclovir on virus replication in patients with chronic hepatitis B virus infection.
Topics: 2-Aminopurine; Adolescent; Adult; Antiviral Agents; Carrier State; Chronic Disease; DNA, Viral; Double-Blind Method; Famciclovir; Female; Hepatitis B; Hepatitis B virus; Humans; Male; Middle Aged; Virus Replication | 1996 |
Long-term results of famciclovir for recurrent or de novo hepatitis B virus infection after liver transplantation.
Topics: 2-Aminopurine; Adult; Antiviral Agents; Famciclovir; Female; Hepatitis B; Humans; Liver Transplantation; Male; Middle Aged; Postoperative Complications; Prospective Studies; Recurrence; Remission Induction; Time Factors | 1999 |
Lamivudine as first- and second-line treatment of hepatitis B infection after liver transplantation.
Topics: 2-Aminopurine; Anti-HIV Agents; Antiviral Agents; Famciclovir; Hepatitis B; Hepatitis B virus; HIV; Humans; Lamivudine; Liver; Liver Transplantation; Prospective Studies; Reverse Transcriptase Inhibitors | 2000 |
[Prevention and treatment of HBV reinfection following liver transplantation].
Topics: 2-Aminopurine; Adult; Antiviral Agents; Biopsy; DNA, Viral; Drug Combinations; Famciclovir; Female; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Humans; Immunoglobulins; Lamivudine; Liver Transplantation; Male; Middle Aged; Postoperative Care; Preoperative Care; Recurrence | 2002 |
39 other study(ies) available for 2-aminopurine and Hepatitis B
Article | Year |
---|---|
A decline in hepatitis B virus surface antigen (hbsag) predicts clearance, but does not correlate with quantitative hbeag or HBV DNA levels.
Topics: 2-Aminopurine; Antiviral Agents; DNA, Viral; Famciclovir; Female; Heart Transplantation; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Lamivudine; Liver Transplantation; Male; Predictive Value of Tests; Treatment Outcome | 2008 |
The use of antiviral monotherapy and combination therapy for patients with hepatitis B virus infection after liver transplantation.
Topics: 2-Aminopurine; Antiviral Agents; Drug Therapy, Combination; Famciclovir; Hepatitis B; Hepatitis B Surface Antigens; Humans; Lamivudine; Liver Function Tests; Liver Transplantation; Recurrence | 2002 |
Treatment of recurrent hepatitis B infection in liver transplant recipients.
Topics: 2-Aminopurine; Adenine; Antiviral Agents; Famciclovir; Hepatitis B; Humans; Interferon-alpha; Lamivudine; Liver Transplantation; Organophosphonates; Recurrence; Reverse Transcriptase Inhibitors | 2002 |
Prophylaxis and treatment of hepatitis B virus reinfection following liver transplantation.
Topics: 2-Aminopurine; Adult; Antiviral Agents; DNA, Viral; Dose-Response Relationship, Drug; Drug Therapy, Combination; Famciclovir; Hepatitis B; Hepatitis B Core Antigens; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Lamivudine; Liver Transplantation; Male; Postoperative Complications; Reverse Transcriptase Inhibitors; Secondary Prevention | 2002 |
Drugs for non-HIV viral infections.
Topics: 2-Aminopurine; Acyclovir; Antiviral Agents; Cytomegalovirus Infections; Drug Resistance, Viral; Famciclovir; Guanine; Hepatitis B; Hepatitis C; Herpes Simplex; Herpes Zoster; Humans; Influenza, Human; Valacyclovir; Valine; Virus Diseases | 2005 |
Lamivudine and famciclovir treatment in HIV patients with acute hepatitis B virus infection and hepatitis B reactivation.
Topics: 2-Aminopurine; Alanine Transaminase; Antiviral Agents; Aspartate Aminotransferases; Famciclovir; Hepatitis B; Hepatitis B virus; HIV Infections; Humans; Lamivudine; Male; Reverse Transcriptase Inhibitors; Virus Activation | 2007 |
Acute necrotico-hemorrhagic pancreatitis after famciclovir prescription.
Topics: 2-Aminopurine; Acute Disease; Alanine Transaminase; Amylases; Antiviral Agents; Bilirubin; Cyclosporine; DNA, Viral; Famciclovir; Fatal Outcome; Hemorrhage; Hepatitis B; Hepatitis B virus; Humans; Kidney Transplantation; Leukocyte Count; Lipase; Male; Middle Aged; Necrosis; Pancreatitis; Postoperative Complications; Prodrugs | 1995 |
Prostaglandin E plus famciclovir--a new concept for the treatment of severe hepatitis B after liver transplantation.
Topics: 2-Aminopurine; Antiviral Agents; Carcinoma, Hepatocellular; DNA, Viral; Famciclovir; Follow-Up Studies; Hepatitis B; Hepatitis B e Antigens; Hepatitis B virus; Humans; Inflammation; Liver Function Tests; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Polymerase Chain Reaction; Prodrugs; Prostaglandins E; Virus Replication | 1994 |
Famciclovir therapy for recurrent hepatitis B virus infection after liver transplantation.
Topics: 2-Aminopurine; Antiviral Agents; DNA, Viral; Famciclovir; Hepatitis B; Humans; Liver Transplantation; Recurrence | 1996 |
Treatment of hepatitis B-related polyarteritis nodosa with famciclovir and interferon alfa-2b.
Topics: 2-Aminopurine; Antiviral Agents; DNA, Viral; Famciclovir; Hepatitis B; Hepatitis B Antibodies; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Polyarteritis Nodosa; Recombinant Proteins; Virus Replication | 1997 |
Pretransplant famciclovir as prophylaxis for hepatitis B virus recurrence after liver transplantation.
Topics: 2-Aminopurine; Adult; Antiviral Agents; DNA, Viral; Famciclovir; Hepatitis Antibodies; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Liver Transplantation; Male; Middle Aged; Premedication; Treatment Outcome | 1997 |
[Famciclovir plus interferon in the treatment of a patient with chronic hepatitis B and severe liver failure].
Topics: 2-Aminopurine; Antiviral Agents; Drug Therapy, Combination; Famciclovir; Hepatitis B; Hepatitis, Chronic; Interferons; Liver Failure; Prodrugs; Time Factors | 1997 |
Hepatitis B virus infection and liver transplantation.
Topics: 2-Aminopurine; Antiviral Agents; Famciclovir; Hepatitis B; Hepatitis B Vaccines; Humans; Immunization, Passive; Immunoglobulins; Immunosuppression Therapy; Interferon-gamma; Lamivudine; Liver Transplantation; Patient Selection | 1997 |
Conversion of recurrent delta-positive hepatitis B infection to seronegativity with famciclovir after liver transplantation.
Topics: 2-Aminopurine; Antigens, Viral; Antiviral Agents; Famciclovir; Hepatitis B; Hepatitis B virus; Hepatitis D; Hepatitis Delta Virus; Humans; Liver Transplantation; Male; Middle Aged | 1997 |
Use of famciclovir to prevent HBV reactivation in HBsAg-positive recipients after allogeneic bone marrow transplantation.
Topics: 2-Aminopurine; Adolescent; Adult; Antiviral Agents; Bone Marrow Transplantation; Famciclovir; Female; Follow-Up Studies; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Incidence; Male; Postoperative Complications; Postoperative Period; Transplantation, Homologous; Virus Activation | 1998 |
Postliver transplant allograft reinfection with a lamivudine-resistant strain of hepatitis B virus: long-term follow-up.
Topics: 2-Aminopurine; Adult; Antiviral Agents; Drug Resistance, Microbial; Famciclovir; Female; Follow-Up Studies; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Liver; Liver Transplantation; Male; Middle Aged; Postoperative Complications; Recurrence; Time Factors | 1998 |
[Prevention of hepatitis B--analysis of cost-effectiveness after liver transplantation].
Topics: 2-Aminopurine; Adult; Antiviral Agents; Cost-Benefit Analysis; Famciclovir; Female; Hepatitis B; Humans; Lamivudine; Liver Transplantation; Male; Middle Aged; Postoperative Complications; Recurrence | 1997 |
Advances in the treatment of viral hepatitis.
Topics: 2-Aminopurine; Antiviral Agents; Famciclovir; Hepatitis B; Hepatitis C; Hepatitis, Viral, Human; Humans; Interferon-alpha; Lamivudine | 1998 |
Resolution of recurrent hepatitis B in two liver transplant recipients treated with famciclovir.
Topics: 2-Aminopurine; Antiviral Agents; Famciclovir; Female; Hepatitis B; Humans; Liver Transplantation; Middle Aged; Postoperative Complications; Recurrence | 1998 |
The sequential occurrence of viral mutations in a liver transplant recipient re-infected with hepatitis B: hepatitis B immune globulin escape, famciclovir non-response, followed by lamivudine resistance resulting in graft loss.
Topics: 2-Aminopurine; Amino Acid Sequence; Antiviral Agents; DNA-Directed DNA Polymerase; DNA, Viral; Drug Resistance; Famciclovir; Hepatitis B; Humans; Immunization, Passive; Immunoglobulins; Lamivudine; Liver; Liver Transplantation; Male; Middle Aged; Molecular Sequence Data; Mutation; Recurrence; Viral Proteins | 1998 |
Absence of mutations in the YMDD motif/B region of the hepatitis B virus polymerase in famciclovir therapy failure.
Topics: 2-Aminopurine; Amino Acid Sequence; Amino Acid Substitution; Antiviral Agents; DNA Replication; Famciclovir; Gene Products, pol; Genetic Variation; Genotype; Hepatitis B; Hepatitis B virus; Humans; Longitudinal Studies; Molecular Sequence Data; Polymerase Chain Reaction; RNA-Directed DNA Polymerase; Sequence Alignment; Treatment Failure | 1999 |
Mutational pattern of hepatitis B virus on sequential therapy with famciclovir and lamivudine in patients with hepatitis B virus reinfection occurring under HBIg immunoglobulin after liver transplantation.
Topics: 2-Aminopurine; Adult; Amino Acid Substitution; Antiviral Agents; DNA Primers; DNA-Directed DNA Polymerase; Famciclovir; Female; Hepatitis B; Hepatitis B e Antigens; Hepatitis B virus; Humans; Immunization, Passive; Immunoglobulins; Lamivudine; Liver Transplantation; Male; Methionine; Middle Aged; Point Mutation; Polymerase Chain Reaction; Prodrugs; Recurrence; Risk Factors; Valine | 1999 |
Is nucleoside analogue monotherapy sufficient for treatment of HBV infection? Lessons from HIV.
Topics: 2-Aminopurine; Anti-HIV Agents; Antiviral Agents; Deoxyguanosine; Famciclovir; Hepatitis B; HIV Infections; Humans; Lamivudine | 1999 |
Selection of multiresistant hepatitis B virus during sequential nucleoside-analogue therapy.
Topics: 2-Aminopurine; Antiviral Agents; DNA-Directed DNA Polymerase; DNA, Viral; Drug Resistance, Microbial; Drug Resistance, Multiple; Drug Therapy, Combination; Famciclovir; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Male; Mutation; Reverse Transcriptase Inhibitors; Viral Load | 2000 |
Lamivudine improves the prognosis of patients with hepatitis B after liver transplantation.
Topics: 2-Aminopurine; Antiviral Agents; Famciclovir; Follow-Up Studies; Hepatitis B; Humans; Lamivudine; Liver Transplantation; Postoperative Complications; Prodrugs; Prognosis; Recurrence; Retrospective Studies; Time Factors; Treatment Failure; Treatment Outcome | 2000 |
Fatal hepatic decompensation in a patient with hepatitis B cirrhosis following famciclovir withdrawal.
Topics: 2-Aminopurine; Adult; Antiviral Agents; Famciclovir; Fatal Outcome; Hepatitis B; Humans; Liver Cirrhosis; Liver Failure; Male; Time Factors; Virus Replication | 2000 |
Comparison of famciclovir and lamivudine in the long-term treatment of hepatitis B infection after liver transplantation.
Topics: 2-Aminopurine; Adult; Aged; Antiviral Agents; DNA, Viral; Famciclovir; Female; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Liver Transplantation; Male; Middle Aged; Multivariate Analysis; Time Factors | 2001 |
Famciclovir treatment in transplant recipients with HBV-related liver disease: disappointing results.
Topics: 2-Aminopurine; Adult; Alanine Transaminase; Antiviral Agents; DNA, Viral; Famciclovir; Female; Follow-Up Studies; Hepatitis B; Hepatitis B virus; Humans; Liver Transplantation; Male; Middle Aged; Pilot Projects; Postoperative Complications; Recurrence; Time Factors | 2001 |
[Current treatment of hepatitis B].
Topics: 2-Aminopurine; Adenine; Anti-Inflammatory Agents; Antiviral Agents; DNA Replication; Famciclovir; Forecasting; Hepatitis B; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Interferon-alpha; Lamivudine; Organophosphonates; Prednisone; Prognosis; Reverse Transcriptase Inhibitors; Time Factors; Virus Replication | 2001 |
[Laboratory diagnosis of hepatitis B].
Topics: 2-Aminopurine; Acute Disease; Antiviral Agents; DNA Replication; DNA, Viral; Drug Resistance; Famciclovir; Genetic Variation; Genotype; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B Vaccines; Hepatitis B virus; Hepatitis B, Chronic; Humans; Immunohistochemistry; Lamivudine; Virus Replication | 2001 |
Severe clinical course of de novo hepatitis B infection after liver transplantation.
Topics: 2-Aminopurine; Adult; Antiviral Agents; Famciclovir; Fatal Outcome; Female; Hepatitis B; Humans; Lamivudine; Liver Transplantation; Middle Aged; Postoperative Complications; Recurrence; Reoperation; Retrospective Studies; Treatment Outcome | 2001 |
Famciclovir treatment of hepatitis B infection following liver transplantation: a long-term, multi-centre study.
Topics: 2-Aminopurine; Adolescent; Adult; Aged; Alanine Transaminase; Antiviral Agents; Child; DNA, Viral; Famciclovir; Female; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Liver Transplantation; Male; Middle Aged; Time Factors; Treatment Outcome | 2001 |
Analysis of hepatitis B viral load decline under potent therapy: complex decay profiles observed.
Topics: 2-Aminopurine; Antiviral Agents; Computer Systems; DNA, Viral; Drug Therapy, Combination; Famciclovir; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Polymerase Chain Reaction; Reproducibility of Results; Reverse Transcriptase Inhibitors; Sensitivity and Specificity; Time Factors; Viral Load | 2001 |
Preoperative antiviral treatment and postoperative prophylaxis in HBV-DNA positive patients undergoing liver transplantation.
Topics: 2-Aminopurine; Adult; Antiviral Agents; DNA, Viral; Famciclovir; Female; Hepatitis B; Humans; Immunoglobulins; Lamivudine; Liver Transplantation; Male; Middle Aged; Recurrence; Retrospective Studies | 2001 |
Failure of combination therapy with lamivudine and famciclovir following lamivudine monotherapy for hepatitis B virus infection in patients coinfected with human immunodeficiency virus-1.
Topics: 2-Aminopurine; Antiviral Agents; Drug Resistance, Microbial; Drug Therapy, Combination; Famciclovir; Hepatitis B; Hepatitis B virus; HIV Infections; HIV-1; Humans; Lamivudine; Male; Mutation; Treatment Failure | 2001 |
Efficacy of famciclovir in the treatment of lamivudine resistance related to an atypical hepatitis B virus mutant.
Topics: 2-Aminopurine; Adult; DNA, Viral; Drug Resistance, Microbial; Famciclovir; Female; Hepatitis B; Hepatitis B virus; Humans; Kidney Failure, Chronic; Kidney Transplantation; Lamivudine; Mutation; Postoperative Complications | 2002 |
[B domain mutations in the polymerase gene of hepatitis B virus during combination therapy with thymosin alpha1 and famciclovir in Chinese asymptomatic HBV carriers].
Topics: 2-Aminopurine; Adjuvants, Immunologic; Antiviral Agents; Binding Sites; DNA Mutational Analysis; DNA, Viral; Drug Resistance, Viral; Drug Therapy, Combination; Famciclovir; Female; Gene Products, pol; Hepatitis B; Hepatitis B virus; Humans; Male; Mutation; Mutation, Missense; Thymalfasin; Thymosin | 2000 |
Seroconversion after the addition of famciclovir therapy in a child with hepatitis B virus infection after liver transplantation who developed lamivudine resistance.
Topics: 2-Aminopurine; Alanine Transaminase; Antiviral Agents; Child, Preschool; DNA, Viral; Drug Resistance, Viral; Famciclovir; Hepatitis B; Humans; Lamivudine; Liver Transplantation; Male | 2002 |
Successful antiviral treatment for fulminant reactivated hepatitis B after autologous stem cell transplantation and prophylaxis during subsequent allogeneic stem cell transplantation.
Topics: 2-Aminopurine; Adult; Antiviral Agents; Famciclovir; Female; Hematopoietic Stem Cell Transplantation; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Transplantation, Autologous; Transplantation, Homologous; Virus Activation | 2002 |